PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 26985457-2 2015 Anastrozole is subject to direct glucuronidation catalyzed by UDP-glucuronosyltransferase1A4 (UGT1A4). Anastrozole 0-11 UDP glucuronosyltransferase family 1 member A4 Homo sapiens 62-92 26985457-2 2015 Anastrozole is subject to direct glucuronidation catalyzed by UDP-glucuronosyltransferase1A4 (UGT1A4). Anastrozole 0-11 UDP glucuronosyltransferase family 1 member A4 Homo sapiens 94-100 26985457-3 2015 Interindividual variability in anastrozole glucuronidation may be affected by UGT1A4 SNPs. Anastrozole 31-42 UDP glucuronosyltransferase family 1 member A4 Homo sapiens 78-84 25203739-6 2014 This paper reviews the role of genetic polymorphisms of CYP19A1, CYP3A4, and UGT1A4 in the responses of female hormone receptor-positive postmenopausal breast cancer patients to anastrozole. Anastrozole 178-189 UDP glucuronosyltransferase family 1 member A4 Homo sapiens 77-83 23371966-6 2013 In this study, we examined individual variability in the glucuronidation of anastrozole and its association with UGT1A4 promoter and coding region polymorphisms. Anastrozole 76-87 UDP glucuronosyltransferase family 1 member A4 Homo sapiens 113-119 23371966-0 2013 Potential role of UGT1A4 promoter SNPs in anastrozole pharmacogenomics. Anastrozole 42-53 UDP glucuronosyltransferase family 1 member A4 Homo sapiens 18-24 24298433-8 2013 UGT1A4 mRNA up regulation was significantly correlated with UGT1A4 protein expression, anastrozole glucuronidation, ERalpha mRNA expression and MRP mRNA expression, but not with ERalpha protein expression. Anastrozole 87-98 UDP glucuronosyltransferase family 1 member A4 Homo sapiens 0-6 23371966-8 2013 Anastrozole glucuronidation was correlated (r = 0.99; P < 0.0001) with lamotrigine glucuronidation (a diagnostic substrate for UGT1A4) and with UGT1A4 mRNA expression levels in human liver microsomes (r = 0.99; P < 0.0001). Anastrozole 0-11 UDP glucuronosyltransferase family 1 member A4 Homo sapiens 130-136 23371966-8 2013 Anastrozole glucuronidation was correlated (r = 0.99; P < 0.0001) with lamotrigine glucuronidation (a diagnostic substrate for UGT1A4) and with UGT1A4 mRNA expression levels in human liver microsomes (r = 0.99; P < 0.0001). Anastrozole 0-11 UDP glucuronosyltransferase family 1 member A4 Homo sapiens 147-153 23371966-9 2013 Recombinant UGT1A4 catalyzed anastrozole glucuronidation, which was inhibited by hecogenin (IC50 = 15 microM), a UGT1A4 specific inhibitor. Anastrozole 29-40 UDP glucuronosyltransferase family 1 member A4 Homo sapiens 12-18 23371966-9 2013 Recombinant UGT1A4 catalyzed anastrozole glucuronidation, which was inhibited by hecogenin (IC50 = 15 microM), a UGT1A4 specific inhibitor. Anastrozole 29-40 UDP glucuronosyltransferase family 1 member A4 Homo sapiens 113-119 21175441-12 2010 Variable activity of CYP3A4 (and probably UGT1A4), possibly due to genetic polymorphisms and drug interactions, may alter anastrozole disposition and its effects in vivo. Anastrozole 122-133 UDP glucuronosyltransferase family 1 member A4 Homo sapiens 42-48